Abstract:Objective To explore the possibility to establish Sjogren's syndrome models by immunizing mice with α-fodrin. Methods Twenty-four 4-week-old BALB/C mice were randomly divided into 4 equal groups to undergo subcutaneous injection of α-Fodrin, submaxillary gland homogenate and glutathione S-transferase (GST) or phosphate-buffered saline (PBS) ( negative control groups) on days 0, 14, 35, and 56 respectively. The drinking amount of water was measured. Blood samples were collected every 2-3 weeks. Munofluorescence assays and ELISA were used to examine the presence of anti-Fodrin, anti-type 3 muscarinic acetylcholine receptor polypeptide (M3RP), anti-SSA, anti-SSB, rheumatoid factor (RF), and antinuclear antibody (ANA). Immunochemistry was used to detect the levels of interferon (IFN)-γ , interleukin (IL)-2, and IL-10. One mouse was killed from each group every 2-3 weeks. The salivary glands were examined. Results (1) No auto-immune antibody was found in the serum samples of the mice before immunization. Antibodies against α-Fodrin and M2RP, and ANA were positive in the serum samples of the α-Fodrin and submaxillary gland homogenate groups since the 35th day after immunization, and were all negative in the 2 control groups. However, no antibodies against SSA, SSB and RF were found in all 4 groups. (2) Lymphocytic infiltration could be seen in the salivary glands of the immunized animals since 50th days after the first immunization of α-Fodrin and submaxillary gland homogenate. Immunohistochemistry showed α-Fodrin expression in the submaxillary glands of the α-Fodfin and submaxillary gland homogenate groups, but not in the PBS and GST controls. (3) The serum IFN-α levels of the α-Fodrin and submaxillary gland homogenate groups were ( 81.6±7.1 ) and ( 90.5±4.9 ) pg/ml respectively, both significantly higher than those of the GST and PBS groups [ ( 30.1±5.9) and (19.3± 6.4) pg/ml respectively, both P< 0.05 ]. The serum IL-2 levels of the α-Fodrin and submaxillary gland homogenate groups were ( 18.7±2.3 ) and ( 19.8±0.9) pg/ml respectively, both significantly higher than those of the GST and PBS groups [ (4.9±1.1 ) and (3.5±1.6) pg/ml respectively, both P< 0.05]. No difference was found in the level of serum IL-10 among the 4 groups. (4) There was no significant difference in the volume of water volume drunk among the 4 groups. Conclusion (1) It is possible to establish mouse mice SS models by immunization with α-Fodrin or submaxillary gland homogenate that are reminiscent of human SS. (2) The appearance of multiple antibodies may be related to the antigen epitope spreading. (3) The pathogenesis of SS may be related to Thl type response.

IgA Antibodies Against Α-Fodrin-derived Polypeptide in Diagnosis of Sj(o)gren's Syndrome

Significance of Anti-Α-fodrin Antibody in the Diagnosis of Sj(o)gren's Syndrome and Its Correlation with Clinical Manifestations

Expression and identification of α-Fodrin and its application in Sj(o)gren 's syndrome

Expression and Identification of Alpha--fodrin and Its Application in Sj&oumlegren's Syndrome

Serum immunogiobulin A and its clinical role in primary Sjogren's syndrome

The relevance of anti-lymphocyte antibody with primary Sj(o)gren syndrome

The value of anti-M3 receptor polypeptide antibody in the diagnosis of sj(o)gren's syndrome

Serum IgA Against Type 3 Muscarinic Acetylcholine Receptor is a Novel Marker in Diagnosis of Sjögren's Syndrome.

The detection of autoantibodies against type 3 muscarinic acetylcholine receptor in Sj(o)gren's syndrome

[The Application of Combined Detection of Autoantibodies in Primary Sjögren's Syndrome].

Establishment of Sj(o)gren's syndrome models by immunization with α-Fodrin: experiment with mice

The diagnostic value of anti-SSA antibody in primary Sj(o)gren's syndrome

Characteristics of Primary Sjögren’s Syndrome Patients with IgG4 Positive Plasma Cells Infiltration in the Labial Salivary Glands

OP0185 Characteristics of Primary Sjögren's Syndrome Patients with IGG4-Positive Plasma Cells in Labial Salivary Glands

Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren's syndrome

Expression of FcγRⅡb on peripheral B cells and its clinical significance in patients with primary Sj(o)gren's syndrome

Identification of a Novel Autoantibody Against Self-Vimentin Specific in Secondary Sjögren’s Syndrome

[Clinical Significance of Autoantibodies Against Ubiquitin Carboxyl Hydrolase L1 Epitopes in the Screening and Diagnosis of Sjögren Syndrome].

Association of Antibodies to Interferon-Inducible Protein-16 With Markers of More Severe Disease in Primary Sjögren's Syndrome

The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.

Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren’s Syndrome in the Early Stage and Indicate Localized Salivary Injury